SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001576885-23-000019
Filing Date
2023-03-28
Accepted
2023-03-28 16:20:57
Documents
6
Effectiveness Date
2023-03-28

Document Format Files

Seq Description Document Type Size
1 S-8 abos-20230328xsx8.htm S-8 61965
2 EX-FILING FEES abos-20230328xexx107.htm EX-FILING FEES 30922
3 EX-5.1 abos-20230328xexx51.htm EX-5.1 7594
4 EX-23.2 abos-20230328xexx232.htm EX-23.2 2372
5 image_0.jpg GRAPHIC 4135
6 image_01.jpg GRAPHIC 4692
  Complete submission text file 0001576885-23-000019.txt   116230
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270902 | Film No.: 23769880
SIC: 2836 Biological Products, (No Diagnostic Substances)